4 pending office actions • 1 art units • 4 examiners • 4 of 4 (100%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| §112 only | 1 (25%) |
| No statute on record | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KRISHNAN, GANAPATHY | 1 | 52.2% | +0.0% |
| LEE, HOI YAN NMN | 1 | 43.1% | +77.9% |
| CHO, DAVID H | 1 | 38.2% | +75.0% |
| GALSTER, SAMUEL LEONARD | 1 | 53.8% | +39.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17597910 | USE OF E-SELECTIN ANTAGONISTS TO ENHANCE THE SURVIVAL OF RECONSTITUTED, BONE MARROW-DEPLETED HOSTS | GALSTER, SAMUEL LEONARD | 120d overdue |
| 17998942 | COMPOUNDS AND METHODS FOR REDUCTION OF CANCER CELL BURDEN AND PROTECTION OF NORMAL HEMATOPOIESIS | CHO, DAVID H | 4d overdue |
| 18001614 | COMPOSITIONS AND METHODS FOR OVERCOMING MICROENVIRONMENT-MEDIATED RESISTANCE VIA E-SELECTIN TARGETING | LEE, HOI YAN NMN | 21d |
| Art Unit | Apps |
|---|---|
| 1693 | 4 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18546609 | PROCESS FOR PREPARING AN E-SELECTIN INHIBITOR INTERMEDIATE | KRISHNAN, GANAPATHY | 1693 | §112 | Non-Final OA | 60d overdue | AI Ready | Aug 16, 2023 |
| 18001614 | COMPOSITIONS AND METHODS FOR OVERCOMING MICROENVIRONMENT-MEDIATED RESISTANCE VIA E-SELECTIN TARGETING | LEE, HOI YAN NMN | 1693 | Other | Final Rejection | 21d | AI Ready | Dec 13, 2022 |
| 17998942 | COMPOUNDS AND METHODS FOR REDUCTION OF CANCER CELL BURDEN AND PROTECTION OF NORMAL HEMATOPOIESIS | CHO, DAVID H | 1693 | Other | Final Rejection | 4d overdue | AI Ready | Nov 16, 2022 |
| 17597910 | USE OF E-SELECTIN ANTAGONISTS TO ENHANCE THE SURVIVAL OF RECONSTITUTED, BONE MARROW-DEPLETED HOSTS | GALSTER, SAMUEL LEONARD | 1693 | §103 | Non-Final OA | 120d overdue | AI Ready | Jan 28, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial